Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
This combination of increased usage and expanded state coverage has increased Medicaid spending on GLP-1s for obesity to more than $500 million in October 2024 alone, with total expenditures reaching $3.5 billion over the past 12 months
An exploratory 12-month follow-up study in patients with PD (NCT03456687) comparing exenatide with placebo has been completed, although its results remain unpublished
Results showed a statistically significant improvement in skin firmness (+22% on cutometer), dermal density (+18% on high-frequency ultrasound) and periorbital wrinkle depth (-25% on profilometry)
Here is the clinical comparison but with an important caveat: these are not head-to-head trial data
Alford, R
Each pen is intended for click-dosed administration without end-user reconstitution
US$ 27.47
US$ 28.50
US$ 23.29
US$ 27.35
US$ 21.81
